The medical definition of menopause is simple: 12 consecutive months without a menstrual period. What comes before that — the years of hormonal fluctuation and decline leading up to it — is perimenopause. And it is poorly understood, commonly missed, and almost universally undertreated.
When It Actually Starts
Clinical data shows perimenopause typically begins 4–10 years before the final menstrual period. Since the average age of menopause in the US is 51–52, perimenopause commonly begins between ages 40–47. But the range is wide — some women begin perimenopausal hormonal changes in their late 30s, and a meaningful percentage of women experience significant symptoms before age 40.
The reason early perimenopause is so frequently missed is that cycles remain regular, at least initially. Physicians (and women themselves) associate perimenopause with irregular periods. But progesterone levels often begin declining years before cycle irregularity emerges. The estrogen fluctuations of early perimenopause can be dramatic — higher peaks and lower troughs than the premenopausal baseline — which produces symptoms even as periods continue normally.
Early Symptoms That Get Dismissed
Sleep disruption — particularly difficulty staying asleep, or waking at 3–4am — is often the earliest perimenopausal symptom. This is driven by declining progesterone (which has GABA-ergic sleep-promoting effects) and early estrogen fluctuations affecting thermoregulation and cortisol patterns. Women presenting with new-onset insomnia in their late 30s or 40s are frequently prescribed sleep aids when hormonal evaluation would be more appropriate.
Mood changes — irritability, anxiety, emotional reactivity, low mood — correlate strongly with the erratic estrogen fluctuations of early perimenopause. Estrogen has profound effects on serotonin, dopamine, and GABA neurotransmitter systems. When estrogen is volatile, so is mood. Many women are started on antidepressants or anxiolytics during perimenopause when the underlying hormonal cause is never addressed.
Brain fog and cognitive symptoms — difficulty concentrating, word-finding problems, memory lapses — are among the most distressing perimenopausal symptoms and the least discussed. Estrogen is neuroprotective and essential for synaptic function. Declining estrogen directly impairs cognitive function in ways that are measurable on objective testing and reversible with hormone optimization.
Heavier or more painful periods — counterintuitively, early perimenopause can cause heavier bleeding rather than lighter. This is driven by progesterone deficiency in the setting of relatively normal or even elevated estrogen — estrogen builds the uterine lining, progesterone limits that buildup. Without adequate progesterone to balance estrogen, the lining thickens excessively and sheds heavily. This is not pathological bleeding — it is hormonal.
Hot flashes before period changes — many women experience vasomotor symptoms years before their cycles become irregular. Hot flashes are caused by estrogen volatility, not estrogen deficiency. In early perimenopause, when estrogen is fluctuating unpredictably, hot flashes can occur even when average estrogen levels are still normal or above normal.
What Appropriate Evaluation Looks Like
Standard FSH testing — the usual tool for diagnosing menopause — is unreliable in perimenopause because FSH fluctuates dramatically from cycle to cycle. A single "normal" FSH does not rule out perimenopause. Estradiol, progesterone (timed to the luteal phase of the cycle), and testosterone should all be included in the evaluation, along with a thorough symptom history.
The most important factor is clinical correlation — matching the hormone levels to how the patient actually feels. A woman with textbook perimenopausal symptoms and technically normal labs is still a woman in perimenopause who deserves treatment.